Multidisciplinary expert consensus on thermal ablation for benign thyroid diseases, low-risk thyroid carcinoma, and metastatic cervical lymph nodes (2025 edition).
10.3760/cma.j.cn112138-20250210-00076
- Collective Name:Interventional Ultrasound Committee of Chinese College of Interventionalists;Tumor Ablation Committee of Chinese College of Interventionalists;Society of Tumor Ablation Therapy of the Chinese Anti-Cancer Association;Ablation Expert Committee of the Chinese Society of Clinical Oncology (CSCO)
- Publication Type:Consensus Development Conference
- MeSH:
Humans;
Thyroid Neoplasms/surgery*;
Consensus;
Lymphatic Metastasis;
Lymph Nodes/pathology*;
Thyroid Diseases/surgery*
- From:
Chinese Journal of Internal Medicine
2025;64(7):614-624
- CountryChina
- Language:Chinese
-
Abstract:
Thermal ablation has proven an effective treatment modality for certain thyroid diseases. However, its indications remain the subject of significant debate both domestically and internationally. Over recent years, several international academic organizations have issued consensus statements, position papers, and guidelines concerning thyroid thermal ablation. In China, the Chinese College of Interventionalists (CCI), in collaboration with other relevant academic organizations, released the "Expert consensus on thermal ablation for thyroid benign nodes, microcarcinoma and metastatic cervical lymph nodes (2018 edition)". This consensus statement received widespread recognition within the field and contributed significantly to the standardization of thyroid thermal ablation therapy in China. With the continuous accumulation of evidence-based medical data, the need for a more stringent and standardized approach to thyroid thermal ablation has become evident. Accordingly, the Interventional Ultrasound Committee of the CCI, in collaboration with multiple academic organizations and experts, conducted extensive discussions and multiple revisions before finalizing the "Multidisciplinary expert consensus on thermal ablation for benign thyroid diseases, low-risk thyroid carcinoma, and metastatic cervical lymph nodes (2025 edition)". This updated consensus builds on the framework of the 2018 edition, refining indications and contraindications, emphasizing standardized treatment, and outlining future directions for research and clinical applications of thyroid thermal ablation technology.
